THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $15,516,000 | -25.7% | 6,411,482 | +11.5% | 0.12% | -29.4% |
Q3 2019 | $20,869,000 | +19.2% | 5,748,980 | -14.6% | 0.16% | +23.5% |
Q2 2019 | $17,504,000 | -38.6% | 6,732,317 | +14.9% | 0.13% | -35.0% |
Q1 2019 | $28,524,000 | +400.4% | 5,857,096 | +291.5% | 0.20% | +341.3% |
Q4 2018 | $5,700,000 | – | 1,496,133 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |